BIOMAT Database Logo BIOMAT Database Logo

Prostaglandin E1 (PGE1), but not prostaglandin E2 (PGE2), alters luteal and endometrial luteinizing hormone (LH) occupied and unoccupied LH receptors and mRNA for LH receptors in ovine luteal tissue to prevent luteolysis. 2010

Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Dept. of HNFAS, University of Hawaii, 1955 East-West Road, Honolulu, HI 96822, USA.

Loss of luteal progesterone secretion at the end of the ovine estrous cycle is via uterine PGF(2)alpha secretion. However, uterine PGF(2)alpha secretion is not decreased during early pregnancy in ewes. Instead, the embryo imparts a resistance to PGF(2)alpha. Prostaglandins E (PGE; PGE(1)+PGE(2)) are increased in endometrium and uterine venous blood during early pregnancy in ewes to prevent luteolysis. Chronic intrauterine infusion of PGE(1) or PGE(2) prevents spontaneous or IUD, estradiol-17beta, or PGF(2)alpha-induced premature luteolysis in nonbred ewes. The objective was to determine whether chronic intrauterine infusion of PGE(1) or PGE(2) affected mRNA for LH receptors, occupied and unoccupied receptors for LH in luteal and caruncular endometrium, and luteal function. Ewes received Vehicle, PGE(1), or PGE(2) every 4h from days 10 to 16 of the estrous cycle via a cathether installed in the uterine lumen ipsilateral to the luteal-containing ovary. Jugular venous blood was collected daily for analysis of progesterone and uterine venous blood was collected on day-16 for analysis of PGF(2)alpha and PGE. Corpora lutea and caruncular endometrium were collected from day-10 preluteolytic control ewes and day-16 ewes treated with Vehicle, PGE(1) or PGE(2) for analysis of the mRNA for LH receptors and occupied and unoccupied receptors for LH. Luteal weights on day-16 in ewes treated with PGE(1) or PGE(2) and day-10 control ewes were similar (P>or=0.05), but were greater (P<or=0.05) than in day-16 Vehicle-treated ewes. Progesterone profiles on days 10-16 differed (P<or=0.05) among treatment groups: PGE(1)>PGE(2)>Vehicle-treated ewes. Concentrations of PGF(2)alpha and PGE in uterine venous plasma on day-16 were similar (P>or=0.05) in the three treatment groups. Luteal mRNA for LH receptors and unoccupied and occupied LH receptors were similar (P>or=0.05) in day-10 control ewes and day-16 ewes treated with PGE(2) and were lower (P<or=0.05) in day-16 Vehicle-treated ewes. PGE(2) prevented loss (P<or=0.05) of day-16 luteal mRNA for LH receptors and occupied and unoccupied LH receptors. Luteal and caruncular tissue mRNA for LH receptors and occupied and unoccupied LH receptors were greater (P<or=0.05) on day-16 of PGE(1)-treated ewes than any treatment group. mRNA for LH receptors and occupied and unoccupied receptors for LH in caruncules were greater (P<or=0.05) in day-16 Vehicle or PGE(2)-treated ewes than in day-10 control ewes. It is concluded that PGE(1) and PGE(2) share some common mechanisms to prevent luteolysis; however, only PGE(1) increased luteal and endometrial mRNA for LH receptors and occupied and unoccupied LH receptors. PGE(2) prevents a decrease in luteal mRNA for LH receptors and occupied and unoccupied receptors for LH without altering endometrial mRNA for LH receptors or occupied and unoccupied receptors for LH.

UI MeSH Term Description Entries
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D011974 Receptors, LH Those protein complexes or molecular sites on the surfaces and cytoplasm of gonadal cells that bind luteinizing or chorionic gonadotropic hormones and thereby cause the gonadal cells to synthesize and secrete sex steroids. The hormone-receptor complex is internalized from the plasma membrane and initiates steroid synthesis. Chorionic Gonadotropin Receptors,Human Chorionic Gonadotropin Receptors,ICSH Receptors,LH Receptors,LH-hCG Receptor,LH-hCG Receptors,Luteinizing Hormone Receptors,Lutropin Receptor,Lutropin Receptors,Receptors, Chorionic Gonadotropin,Receptors, Human Chorionic Gonadotropin,Receptors, Interstitial Cell-Stimulating Hormone,Receptors, Luteinizing Hormone,hCG Receptors,Chorionic Gonadotropin Receptor,Human Chorionic Gonadotropin Receptor,LH Receptor,Luteinizing Hormone Receptor,Receptors, ICSH,Receptors, Interstitial Cell Stimulating Hormone,Receptors, LH-hCG,Receptors, Lutropin,Receptors, hCG,hCG Receptor,Gonadotropin Receptor, Chorionic,Gonadotropin Receptors, Chorionic,Hormone Receptor, Luteinizing,Hormone Receptors, Luteinizing,LH hCG Receptor,LH hCG Receptors,Receptor, Chorionic Gonadotropin,Receptor, LH,Receptor, LH-hCG,Receptor, Luteinizing Hormone,Receptor, Lutropin,Receptor, hCG,Receptors, LH hCG
D003338 Corpus Luteum The yellow body derived from the ruptured OVARIAN FOLLICLE after OVULATION. The process of corpus luteum formation, LUTEINIZATION, is regulated by LUTEINIZING HORMONE. Corpora Lutea,Lutea, Corpora
D003341 Luteolysis Degradation of CORPUS LUTEUM. In the absence of pregnancy and diminishing trophic hormones, the corpus luteum undergoes luteolysis which is characterized by the involution and cessation of its endocrine function. Corpus Luteum Regression,Luteal Regression,Regression, Corpus Luteum,Regression, Luteal
D004717 Endometrium The mucous membrane lining of the uterine cavity that is hormonally responsive during the MENSTRUAL CYCLE and PREGNANCY. The endometrium undergoes cyclic changes that characterize MENSTRUATION. After successful FERTILIZATION, it serves to sustain the developing embryo. Endometria
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression
D000527 Alprostadil A potent vasodilator agent that increases peripheral blood flow. PGE1,Prostaglandin E1,Caverject,Edex,Lipo-PGE1,Minprog,Muse,PGE1alpha,Prostaglandin E1alpha,Prostavasin,Prostin VR,Prostine VR,Sugiran,Vasaprostan,Viridal,Lipo PGE1
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated

Related Publications

Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Effects of prostaglandin E1 or E2 (PGE1; PGE2) on luteal function and binding of luteinizing hormone in nonpregnant ewes.
February 1985, Prostaglandins,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Differences in the lateral mobility of receptors for luteinizing hormone (LH) in the luteal cell plasma membrane when occupied by ovine LH versus human chorionic gonadotropin.
January 1985, Endocrinology,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Sensitivity of the early luteal phase ovine cervix to prostaglandin E2 (PGE2) and expression of EP3 receptor mRNA.
January 1998, Research in veterinary science,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Activity of phospholipase C in ovine luteal tissue in response to PGF2 alpha, PGE2 and luteinizing hormone.
May 1991, Prostaglandins,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Cytochalasins and colchicine increase the lateral mobility of human chorionic gonadotropin-occupied luteinizing hormone receptors on ovine luteal cells.
January 1988, Endocrinology,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Receptors for human luteinizing hormone in human corpora luteal tissue.
January 1973, The Journal of clinical endocrinology and metabolism,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Prostaglandin F2 alpha and progesterone release in vitro by ovine luteal tissue during induced luteolysis.
January 1979, Advances in experimental medicine and biology,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Prostaglandin F2 alpha inhibits luteinizing hormone (LH)-induced increase in LH receptor binding to isolated rat luteal cells.
December 1984, Endocrinology,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Identification and characterization of luteinizing hormone-releasing hormone (LH-RH) receptors in the endometrial tissue of pregnant rats.
July 1984, Scientia Sinica. Series B, Chemical, biological, agricultural, medical & earth sciences,
Y S Weems, and T M Nett, and L A Rispoli, and T L Davis, and D L Johnson, and T Uchima, and A Raney, and E Lennon, and J Pang, and T Harbert, and G Bowers, and K Goto, and A Ong, and N Tsutahara, and R D Randel, and C W Weems
Differential binding affinities of rat testis luteinizing hormone (LH) receptors for human chorionic gonadotropin, human LH, and ovine LH.
May 1981, Endocrinology,
Copied contents to your clipboard!